NGS Streamlines Biomarker Testing in Solid Tumors
Chen, PharmD, MS, BCOP, CPP, discusses the benefits of next-generation sequencing (NGS) in improving biomarker testing and treatment planning for solid tumors.
- NGS enhances biomarker testing
- Improves treatment planning for solid tumors
Experts, including Traina, MD, FASCO, and Demetria Smith-Graziani, MD, MPH, among others, share insights on the advancements in biomarker testing and treatment planning.
Authors include Mark Agulnik, MD, Mrinal M. Zuckerman, MD, and many others, highlighting the collaborative effort in understanding the role of NGS in oncology.
Author's summary: NGS improves biomarker testing in solid tumors.
More News
- Après la tentative de coup d'Etat au Bénin, la menace du pouvoir kaki plus présente que jamais en Afrique
- Women’s Big Bash League 2025-26 results
- Tartan Army set for ‘big bash’ in Boston with two games in New England
- IndiGo Flights Cancellation Live Updates
- Vilnius Airport grounds flights after suspected Belarusian balloons detected
- Breaking: Loyalist troops foil coup attempt in Benin
- GRIDLOCK Definition & Meaning
- Canada's Air Transat to suspend flights
- Benin Rejects Claims of a Coup by Opposition Soldiers
- No quick fix for ‘tiresome’ M50 gridlock, Minister says